Analysis shows improved outcomes for residual metaplasia in patients post-endoscopic submucosal dissection, suggesting better strategies for esophageal neoplasia management.
Endoscopic treatment of early Barrett's neoplasia has been established as a two-step approach [1]. In the first step, endoscopic resection for all visible neoplasia is performed. Endoscopic submucosal dissection (ESD) is globally accepted as a treatment for visible lesions, enabling a high rate of en bloc R0 resection [2]. In the second step, the ablation of all residual metaplasia is necessary to avoid the recurrence of neoplasia [1]. Thermal radiofrequency ablation (RFA) is currently used for this indication and obtains a significantly higher rate of complete eradication of metaplasia [3]. Despite RFA's success, however, there is a subset of patients in whom complete eradication of metaplasia cannot be achieved [3]. Recently some non-thermal procedures were proposed. Our device is a powered non-thermal resection device [3] [4] [5] associating a rotative blade with suction.
No takes yet. Share an insight, caveat, or question.
Ciccone et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: